Biomarker Center of Excellence
|
The Biomarker Center of Excellence supports your drug development needs by providing a full suite of biomarker assay development and validation services as well as biomarker testing services (both large and small scale) across the drug development continuum, from early proof concept to commercial laboratory testing:
Nonclinical biomarker services:
|
Clinical biomarker services:
- Full assay portfolio
- Assay development and validation
- Assay production
|
Biomarker COE Webinar Series
 Learn how the Covance Biomarker Center of Excellence is working to provide you with the most comprehensive and integrated biomarker solutions in the industry.
View More Information
 |
News from the Covance
Biomarker Center of Excellence (BCOE)
Pain and the Prognosis for Dementia
After attending the recent New York Academy of Sciences (NYAS) symposium 'The Pharmacology of Aging: Why Age Matters,' Biomarker Center of Excellence Neuroscience Therapeutic Area Lead Rober Martone wrote a short review on pain and the prognosis for dementia.
|
Interested in previous news? Click here for the news archive.
|
|
|
 |
In the News: Biomarkers & Personalized Medicine
Seeing Biomarkers with the Naked Eye
A new ultra-sensitive and label-free technique to detect molecules has been developed by researchers at Boston University. The technique is based on a resonant scattering phenomena in plasmonic nanohole devices and allows cancer biomarkers to be seen with the naked eye.
[nanotechweb.org]
Lack Of Diagnostics Slows Personalized Medicine
According to the Tufts Center for the Study of Drug Development, many third-party payers are skeptical about the usefulness of certain companion diagnostics and are either denying or restricting test reimbursement.
[Pharmalot]
|
|